Intel Corporation (ETR:INL)

Marinus Pharmaceuticals Statistics

Total Valuation

Intel has a market cap or net worth of EUR 73.79 billion. The enterprise value is 105.73 billion.

Market Cap	73.79B
Enterprise Value	105.73B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Aug 7, 2024

Share Statistics

Current Share Class	4.38B
Shares Outstanding	n/a
Shares Change (YoY)	+1.79%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.37B

Valuation Ratios

PE Ratio	n/a
Forward PE	90.00
PS Ratio	1.63
PB Ratio	0.82
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.94, with an EV/FCF ratio of -11.32.

EV / Earnings	-6.04
EV / Sales	2.30
EV / EBITDA	12.94
EV / EBIT	n/a
EV / FCF	-11.32

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.48.

Current Ratio	1.24
Quick Ratio	0.67
Debt / Equity	0.48
Debt / EBITDA	5.37
Debt / FCF	-4.64
Interest Coverage	-2.70

Financial Efficiency

Return on equity (ROE) is -18.62% and return on invested capital (ROIC) is -1.03%.

Return on Equity (ROE)	-18.62%
Return on Assets (ROA)	-0.85%
Return on Invested Capital (ROIC)	-1.03%
Return on Capital Employed (ROCE)	-1.73%
Revenue Per Employee	415,934
Profits Per Employee	-160,699
Employee Count	108,900
Asset Turnover	0.27
Inventory Turnover	3.15

Taxes

In the past 12 months, Intel has paid 7.86 billion in taxes.

Income Tax	7.86B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.13% in the last 52 weeks. The beta is 1.15, so Intel's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-14.13%
50-Day Moving Average	18.63
200-Day Moving Average	19.94
Relative Strength Index (RSI)	33.95
Average Volume (20 Days)	113,806

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.50

Income Statement

In the last 12 months, Intel had revenue of EUR 45.30 billion and -17.50 billion in losses. Loss per share was -4.04.

Revenue	45.30B
Gross Profit	14.91B
Operating Income	-2.32B
Pretax Income	-10.11B
Net Income	-17.50B
EBITDA	7.85B
EBIT	-2.32B
Loss Per Share	-4.04

Balance Sheet

The company has 18.10 billion in cash and 43.32 billion in debt, giving a net cash position of -24.82 billion.

Cash & Cash Equivalents	18.10B
Total Debt	43.32B
Net Cash	-24.82B
Net Cash Per Share	n/a
Equity (Book Value)	90.26B
Book Value Per Share	19.09
Working Capital	7.18B

Cash Flow

In the last 12 months, operating cash flow was 8.60 billion and capital expenditures -17.94 billion, giving a free cash flow of -9.34 billion.

Operating Cash Flow	8.60B
Capital Expenditures	-17.94B
Free Cash Flow	-9.34B
FCF Per Share	n/a

Margins

Gross margin is 32.92%, with operating and profit margins of -5.13% and -38.64%.

Gross Margin	32.92%
Operating Margin	-5.13%
Pretax Margin	-22.31%
Profit Margin	-38.64%
EBITDA Margin	17.34%
EBIT Margin	-5.13%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.68%.

Dividend Per Share	0.11
Dividend Yield	0.68%
Dividend Growth (YoY)	-50.58%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.79%
Shareholder Yield	-1.10%
Earnings Yield	-23.72%
FCF Yield	-12.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Intel has an Altman Z-Score of 1.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	3